| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
78,002 |
70,730 |
$10.11M |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
3,183 |
2,788 |
$101K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
38,109 |
24,991 |
$62K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
43,230 |
26,045 |
$22K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
7,362 |
4,659 |
$12K |
| 90677 |
|
839 |
562 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
550 |
482 |
$10K |
| 90686 |
|
6,679 |
4,403 |
$10K |
| 90651 |
|
1,120 |
760 |
$9K |
| 99199 |
Unlisted special service, procedure or report |
764 |
675 |
$8K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
410 |
273 |
$8K |
| 0360 |
|
76 |
66 |
$6K |
| 90715 |
|
1,345 |
873 |
$6K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
152 |
149 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
177 |
166 |
$5K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
608 |
559 |
$3K |
| 90750 |
|
121 |
80 |
$3K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,146 |
1,373 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,634 |
2,077 |
$2K |
| 0760 |
|
906 |
858 |
$2K |
| 99070 |
|
38 |
36 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
270 |
218 |
$2K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
7,589 |
1,262 |
$2K |
| 90746 |
|
189 |
139 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
469 |
310 |
$2K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,060 |
2,359 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,374 |
834 |
$1K |
| 90656 |
|
983 |
665 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,746 |
980 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
49 |
49 |
$1K |
| 92552 |
|
8,961 |
5,349 |
$1K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,603 |
2,108 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
549 |
401 |
$932.69 |
| 97750 |
|
763 |
413 |
$914.52 |
| 81003 |
|
8,355 |
5,264 |
$686.47 |
| 71046 |
Radiologic examination, chest; 2 views |
81 |
79 |
$624.70 |
| 90734 |
|
914 |
533 |
$573.89 |
| 99152 |
|
41 |
40 |
$499.15 |
| 1159F |
|
18,146 |
16,764 |
$494.30 |
| 90670 |
|
1,811 |
1,181 |
$445.52 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
160 |
129 |
$407.64 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
96 |
95 |
$366.36 |
| 90688 |
|
365 |
217 |
$357.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
253 |
175 |
$355.25 |
| 90620 |
|
257 |
165 |
$341.00 |
| 0270 |
|
73 |
65 |
$330.25 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,832 |
1,043 |
$312.11 |
| 99153 |
Mod sedat endo service >5yrs |
25 |
24 |
$289.04 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
401 |
230 |
$217.53 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
50 |
49 |
$207.71 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
64 |
61 |
$194.39 |
| J3490 |
Unclassified drugs |
34 |
14 |
$164.87 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
64 |
61 |
$155.83 |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
15 |
15 |
$146.67 |
| 85018 |
|
10,501 |
6,736 |
$138.78 |
| 81025 |
|
491 |
354 |
$118.53 |
| 90633 |
|
1,255 |
745 |
$109.99 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
460 |
312 |
$109.94 |
| 99381 |
|
13 |
12 |
$102.55 |
| 97802 |
|
28 |
15 |
$100.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
25 |
25 |
$93.08 |
| 94150 |
|
92 |
52 |
$86.84 |
| 97597 |
|
95 |
50 |
$84.22 |
| 90723 |
|
1,657 |
1,079 |
$67.46 |
| 36415 |
Collection of venous blood by venipuncture |
1,426 |
1,284 |
$64.85 |
| 90647 |
|
1,516 |
983 |
$63.00 |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
181 |
135 |
$60.48 |
| 92553 |
|
1,378 |
731 |
$55.52 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
24 |
14 |
$41.16 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
114 |
114 |
$28.77 |
| 90680 |
|
573 |
383 |
$27.00 |
| 90674 |
|
68 |
57 |
$25.00 |
| 82962 |
|
14 |
14 |
$19.12 |
| 86580 |
|
35 |
30 |
$16.80 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
764 |
703 |
$13.78 |
| 90685 |
|
546 |
369 |
$9.00 |
| 1160F |
|
10,137 |
9,470 |
$0.00 |
| 3077F |
|
1,120 |
1,084 |
$0.00 |
| 3078F |
|
2,446 |
2,355 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
49 |
27 |
$0.00 |
| 0516 |
|
15 |
14 |
$0.00 |
| 90653 |
|
48 |
42 |
$0.00 |
| 90710 |
|
21 |
12 |
$0.00 |
| Z7500 |
|
45 |
45 |
$0.00 |
| 90662 |
|
26 |
25 |
$0.00 |
| 90700 |
|
106 |
56 |
$0.00 |
| 90707 |
|
49 |
27 |
$0.00 |
| 90648 |
|
58 |
32 |
$0.00 |
| 90678 |
|
24 |
24 |
$0.00 |
| 3008F |
|
17,247 |
16,459 |
$0.00 |
| 3080F |
|
366 |
359 |
$0.00 |
| 3075F |
|
1,538 |
1,508 |
$0.00 |
| 3074F |
|
2,177 |
2,102 |
$0.00 |
| 3079F |
|
1,976 |
1,932 |
$0.00 |
| Z1034 |
|
405 |
293 |
$0.00 |
| 90716 |
|
76 |
43 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
144 |
143 |
$0.00 |
| 90696 |
|
45 |
25 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
180 |
169 |
$0.00 |
| 93000 |
|
44 |
44 |
$0.00 |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
12 |
12 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
16 |
15 |
$0.00 |
| G9964 |
Patient received at least one well-child visit with a pcp during the performance period |
45 |
45 |
$0.00 |
| 3044F |
|
14 |
14 |
$0.00 |